FDA reverses course and will review Moderna’s mRNA-based flu vaccine
FDA reverses course and will review Moderna’s mRNA-based flu vaccine
www.theguardian.com
FDA reverses course and will review Moderna’s mRNA-based flu vaccine
US drug regulator originally refused to consider application, fueling critics’ concern about alleged ‘anti-vaccine agenda’
